Oorsprong van het eerstegraads netwerk van Frederica Draghi
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Kuste Biopharma SAS
Kuste Biopharma SAS Pharmaceuticals: MajorHealth Technology Kuste Biopharma SAS engages in the development of therapies for unmet medical inflammatory. The company was founded in 2019 and is headquartered in Lyon, France.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frederica Draghi via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
IXALTIS SAS
IXALTIS SAS Pharmaceuticals: MajorHealth Technology IXALTIS SAS develops therapeutics to treat genitourinary tract disorders with unsatisfied medical need. The company was founded by Christian Chavy, Philippe Lluel, Roberto Gradnik, Stefano Palea, Pascal Rischmann, and Xavier Gamé in 2012 and is headquartered in Archamps, France. | Pharmaceuticals: Major | Founder Director/Board Member Corporate Officer/Principal | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stallergenes, Inc. | Director/Board Member | ||
Stallergenes Belgium SA
Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Stallergènes Belgium NV manufactures pharmaceutical products used for the treatment of allergies. It produces desensitization products and treatment for allergies. The firm has offices in Belgium, Czech Republic, Germany, Spain, France, Italy, the Netherlands, Austria, Poland, Portugal, and Slovenia. The company was founded in 1962 and is headquartered in Waterloo, Belgium. | Pharmaceuticals: Major | Chairman | |
European Biopharmaceutical Enterprises
European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Biotechnology | President | |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Director/Board Member | |
ImmunID SAS
ImmunID SAS Medical SpecialtiesHealth Technology ImmunID SAS researches and develops diagnostic tools for monitoring immune cell repertoire. It specializes in combinatorial repertoire analysis. The firm provides tests which translate the complexity of the immune system into clinically meaningful data. The company was founded by Nicolas Pasqual and Sébastien Weisbuch on March 25, 2005 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member | |
Sofimac Innovation SAS
Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member | |
University of Gothenburg | College/University | Doctorate Degree | |
The Swedish-American Chamber of Commerce, Inc.
The Swedish-American Chamber of Commerce, Inc. Miscellaneous Commercial ServicesCommercial Services The Swedish-American Chamber of Commerce, Inc. is a business organization that provides contacts, partners, and business services to help businesses succeed in the United States. The non-profit company is based in New York, NY, with its office located at 900 3rd Avenue, 29th floor. The chamber offers memberships, marketing opportunities, and events and programming, including the largest transatlantic meet up for female leaders, entrepreneurs, and investors. With over 70 events and three large conferences arranged every year, the chamber's calendar most likely includes the right events for all business needs. | Miscellaneous Commercial Services | Director/Board Member | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
STALLERGENES | Pharmaceuticals: Major | Chief Executive Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
PHARNEXT SCA | Biotechnology | Chairman | |
Amolyt Pharma SAS
Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member | |
Ventac Partners GmbH
Ventac Partners GmbH Miscellaneous Commercial ServicesCommercial Services Ventac Partners GMBH offers life sciences consultancy services. Its consulting services include due diligence, education and training, market analysis, product development and valuation. The company was founded by Mikael Oerum in 2002 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Chairman | |
Genextra SpA
Genextra SpA Investment ManagersFinance Genextra SpA (Genextra) is a venture capital firm founded in 2004 by Franceso Micheli and Saverio Minucci. The firm is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Investment Managers | Founder | |
Università degli Studi di Roma Tor Vergata | College/University | Undergraduate Degree | |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Part of Stallergenes Greer Ltd., Stallergenes Italia Srl is an Italian company that offers a range of products for the diagnosis and treatment of allergic diseases, with a focus on allergen immunotherapy. Stallergenes Italia is based in Milan, IT. The company has a deep understanding of allergens and is committed to innovation. | Medical Distributors | Director/Board Member | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | President | |
Merck Serono SAS
Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Operating Officer | |
Migliara Kaplan & Associates
Migliara Kaplan & Associates Miscellaneous Commercial ServicesCommercial Services Part of Interpublic Group of Cos., Inc., Migliara Kaplan & Associates is a full-service health care marketing company. The company is based in Owings Mills, MD. The company was founded by Joseph M. Migliara, Harris Kaplan. Migliara Kaplan & Associates was acquired by NFO Research, Inc. on January 09, 1996 for $15.20 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Merck Santé SAS manufactures pharmaceutical products. The company is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Schweizerisches Institut für Betriebsökonomie AG | College/University | Graduate Degree | |
GENTIUM S.P.A. (ADR) | Pharmaceuticals: Major | Director/Board Member | |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Moleac Pte Ltd.
Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore. | Pharmaceuticals: Major | Chairman | |
JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
STALLERGENES GREER | Pharmaceuticals: Major | Director/Board Member | |
MindMaze SA
MindMaze SA Medical SpecialtiesHealth Technology MindMaze SA engages in the development of a neuro-inspired computing platform that captures brain activity upon intent, creating a new operating system for computers. It also engages in the use of virtual reality to rehabilitate the brains of stroke patients. The company was founded by Tej Tadi in 2012 and is headquartered in Lausanne, Switzerland. | Medical Specialties | Director/Board Member | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Chairman | |
UCB Pharma Ltd.
UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi-Synthélabo Ltd.
Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Procom RX | Chairman | ||
Noorik Biopharmaceuticals AG
Noorik Biopharmaceuticals AG Pharmaceuticals: MajorHealth Technology Noorik Biopharmaceuticals AG is a Swiss drug development company. The private company is based in Basel, Switzerland. | Pharmaceuticals: Major | Chairman | |
Damien AG | Director/Board Member |
Statistieken
Internationaal
Zwitserland | 10 |
Frankrijk | 9 |
Verenigde Staten | 8 |
Italië | 8 |
België | 5 |
Sectoraal
Health Technology | 35 |
Commercial Services | 5 |
Finance | 4 |
Consumer Services | 4 |
Retail Trade | 2 |
Operationeel
Director/Board Member | 37 |
Chairman | 14 |
Corporate Officer/Principal | 9 |
Independent Dir/Board Member | 9 |
Chief Executive Officer | 8 |
Sterkste connecties
Insiders | |
---|---|
Elmar Schnee | 31 |
Lena Elisabeth Svanberg | 16 |
Roberto Gradnik | 11 |
Daniele Scarinci | 7 |
Mario Caria | 4 |
- Beurs
- Insiders
- Frederica Draghi
- Bedrijfsconnecties